A popular antidepressant has been recalled due to potential risks associated with a carcinogen. The recall was announced by the FDA and affects a significant number of bottles, with reports suggesting nearly 375,000 bottles are involved. The antidepressant is reported to contain high levels of a potentially cancer-causing substance, prompting the recall.